Peter Voorhees named associate director of clinical research at Wake Forest

Samra Turajlić appointed director of Cancer Research UK Manchester Institute

Samra Turajlić was appointed the director of the Cancer Research UK Manchester Institute.

June 20, 2025

Researchers identify key B-cell lymphoma traits linked with greatest benefit from CD19 CAR T-cell therapy

In the largest study of its kind, researchers from The University of Texas MD Anderson Cancer Center identified three subgroups of patients with large B-cell lymphoma who have different levels of benefit from CD19 chimeric antigen receptor T cell therapy.

June 20, 2025

Vol.51 No.24

Loss of Y chromosome “cripples” immune cells, University of Arizona researcher finds
Cells with LOY may induce LOY in otherwise healthy cells—a finding that could explain variability in CAR T-cell therapy response

Two years ago, Dan Theodorescu made a discovery that could alter biology textbooks: The Y chromosome, widely considered to be a “functional wasteland,” has functions beyond sex determination—and in fact plays a role in cancer biology.

Texas Oncology breaks ground on $120M cancer center in Plano

Texas Oncology on June 4 broke ground on a $120 million cancer center in Plano, marking a milestone for cancer care in North Texas.

June 06, 2025

Vol.51 No.22

In Brief

Northwell Cancer Institute opens $1.1M expansion at R.J. Zuckerberg Cancer Center

The Northwell Health Cancer Institute on June 2 opened a $1.1 million, 2,400-square-foot expansion of outpatient infusion at the R.J. Zuckerberg Cancer Center.

June 06, 2025

Vol.51 No.22

In Brief

CAR T Vision Coalition launches with goal of doubling patients treated with the curative potential of CAR T-cell therapy by 2030

On May 30, an international coalition announced the launch of CAR T Vision, a coalition that aims to unite stakeholders around the shared ambition that every eligible patient should have the opportunity for cure with CAR T-cell therapy.

May 30, 2025

Vol.51 No.21

Peter Voorhees named associate director of clinical research at Wake Forest

YOU MAY BE INTERESTED IN

Samra Turajlić appointed director of Cancer Research UK Manchester Institute

Researchers identify key B-cell lymphoma traits linked with greatest benefit from CD19 CAR T-cell therapy

Loss of Y chromosome “cripples” immune cells, University of Arizona researcher finds
Cells with LOY may induce LOY in otherwise healthy cells—a finding that could explain variability in CAR T-cell therapy response

Texas Oncology breaks ground on $120M cancer center in Plano

Northwell Cancer Institute opens $1.1M expansion at R.J. Zuckerberg Cancer Center

CAR T Vision Coalition launches with goal of doubling patients treated with the curative potential of CAR T-cell therapy by 2030

Renew today!

Subscriber content

Never miss an issue!

Login

Peter Voorhees named associate director of clinical research at Wake Forest

YOU MAY BE INTERESTED IN

Samra Turajlić appointed director of Cancer Research UK Manchester Institute

Researchers identify key B-cell lymphoma traits linked with greatest benefit from CD19 CAR T-cell therapy

Loss of Y chromosome “cripples” immune cells, University of Arizona researcher findsCells with LOY may induce LOY in otherwise healthy cells—a finding that could explain variability in CAR T-cell therapy response

Texas Oncology breaks ground on $120M cancer center in Plano

Northwell Cancer Institute opens $1.1M expansion at R.J. Zuckerberg Cancer Center

CAR T Vision Coalition launches with goal of doubling patients treated with the curative potential of CAR T-cell therapy by 2030

Never miss an issue!

Login

Loss of Y chromosome “cripples” immune cells, University of Arizona researcher finds
Cells with LOY may induce LOY in otherwise healthy cells—a finding that could explain variability in CAR T-cell therapy response